A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104) is a research paper published in Cancer (2023). On theSindex it has a DataRank of 0.481. It has been cited 12 times, with 12 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0.0960
From 8 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 12 citers.
NCI NIH HHS
Grant: UG1 CA232760
NCI NIH HHS
Grant: U10 CA180821
NCI NIH HHS
Grant: U24 CA196171
NCI NIH HHS
Grant: UG1 CA233327
NCI NIH HHS
Grant: UG1 CA189863
NCI NIH HHS
Grant: UG1 CA233178
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA166978
NCI NIH HHS
Grant: U10 CA180882
NCI NIH HHS
Grant: UG1 CA233247
NCI NIH HHS
Grant: UG1 CA233290
MeSH Terms
Keywords